08/08/2025
Trichomoniasis: Symptoms, Consequences, Complications, and Diagnosis
1. Introduction to Trichomoniasis (Trichomoniasis) 1.1. What is Trichomonas vaginalis? Trichomoniasis, is a very common sexually transmitted infection (STI), caused by a single-celled protozoan parasite named Trichomonas vaginalis. It is important to note that Trichomoniasis is caused by a parasite, not a virus. It is the most common non-viral STI globally and can be completely cured with medication. […]
08/08/2025
Trichomoniasis Overview
1. Introduction to Trichomoniasis 1.1. What is Trichomonas vaginalis? Trichomoniasis is a very common sexually transmitted infection (STI), caused by a single-celled protozoan parasite named Trichomonas vaginalis. It is important to note that Trichomoniasis is caused by a parasite, not a virus. It is the most common non-viral STI globally and can be completely cured with medication. […]
08/08/2025
The Importance of Accurate Testing and Treatment in Gynecological Issues
Introduction In daily life, many women, when facing gynecological issues such as abnormal discharge, pain, or vaginal itching, often tend to buy over-the-counter medication at the pharmacy or rely on personal experience to guess the cause and treat it. We understand that these issues can make you feel shy or anxious, but gynecological care is […]
07/08/2025
STIs: Understanding and Preventing Sexually Transmitted Infections
Introduction to STIs Sexually Transmitted Infections (STIs) are a serious public health issue, affecting millions of people worldwide. According to data from the U.S. Centers for Disease Control and Prevention (CDC), 2023 recorded over 2.4 million STI cases in the U.S., including chlamydia, gonorrhea, and syphilis, with 3,882 cases of congenital syphilis, resulting in 279 […]
04/08/2025
PrEP and PEP: Understanding the Difference
PrEP (Pre-Exposure Prophylaxis) is a method of using antiviral medication before potential HIV exposure to reduce the risk of infection. WHO defines PrEP as “the use of anti-HIV medication by HIV-negative people to reduce the risk of HIV acquisition” [1]. Conversely, PEP (Post-Exposure Prophylaxis) is medication taken for 28 days after a potential HIV exposure situation, which […]



